CONCORD exchange filings, corporate actions and results
12 Aug 2026
⚑ Filing
Concord Drugs Ltd - 538965 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE filing · raw filing ↗
10 Aug 2026
⚑ Result
Q1 FY27 results filed — revenue ₹21 Cr (+53.9% YoY), PAT ₹1 Cr (−NaN% YoY)BSE filing · raw filing ↗
10 Aug 2026
⚑ Filing
Concord Drugs Ltd - 538965 - Board Meeting Outcome for Outcome Of Board MeetingBSE filing · raw filing ↗
25 Nov 2025
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
25 Nov 2025
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
25 Nov 2025
⚑ Filing
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE filing · raw filing ↗
NOT BUILT YETPer-item summaries & sentiment — not built yetOne-line plain-language summaries and a sentiment read of every filing. Not built yet. When they exist they will describe — never advise.
Official filings & corporate actions · newest first
